-
1 × $167.00 -
1 × $39.00 -
1 × $369.00 -
1 × $3.50 -
1 × $69.00 -
2 × $278.00 -
2 × $199.00 -
1 × $1,399.00 -
1 × $699.00 -
2 × $2.20 -
1 × $1.90 -
1 × $199.00 -
2 × $69.00 -
1 × $498.00 -
1 × $730.00 -
1 × $159.00 -
1 × $229.00 -
2 × $193.00 -
1 × $139.00 -
2 × $120.00 -
3 × $996.00 -
-
1 × $119.10 -
1 × $149.00 -
1 × $496.00 -
2 × $866.00 -
1 × $2,997.00 -
1 × $69.00 -
1 × $666.00 -
1 × $69.00 -
1 × $66.00 -
1 × $349.00 -
-
1 × $1.50 -
1 × $731.00 -
1 × $1,399.00 -
1 × $269.00 -
1 × $165.00 -
2 × $139.00 -
1 × $7.00 -
-
1 × $15.00 -
-
1 × $75.00 -
1 × $129.00
Natdac (Daclatasvir 60mg)is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:
1.Sustainedvirologicresponse(SVR12)ratesarereducedingenotype3patientswith cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.
Reviews
There are no reviews yet.